Current Liabilities
Total Current Liabilities
United Therapeutics Total Current Liabilities increased by 6.9% to $599.10M in Q1 2026 compared to the prior quarter. Year-over-year, this metric declined by 17.0%, from $721.50M to $599.10M. Over 5 years (FY 2020 to FY 2025), Total Current Liabilities shows an upward trend with a 11.6% CAGR. This increase may warrant attention — for this metric, lower values are generally preferred.
Analysis
StatementBalance Sheet Statement
SectionCurrent Liabilities
CategoryLiquidity
SignalLower is better
VolatilityModerate
First reportedQ4 2015
Last reportedQ1 2026
How to read this metric
An increase suggests rising short-term obligations, which may strain liquidity if not matched by current asset growth.
Detailed definition
This is the aggregate sum of all financial obligations that the company is required to settle within one year or the cur...
Peer comparison
Universal metric for assessing short-term solvency across all industries.
Metric ID:
total_current_liabilitiesHistorical Data
20 periods
| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $311.40M | $320.00M | $305.40M | $292.60M | $331.50M | $315.90M | $343.20M | $324.60M | $370.30M | $744.10M | $804.40M | $860.60M | $832.30M | $873.40M | $738.10M | $721.50M | $527.10M | $546.30M | $560.60M | $599.10M |
| QoQ Change | — | +2.8% | -4.6% | -4.2% | +13.3% | -4.7% | +8.6% | -5.4% | +14.1% | +100.9% | +8.1% | +7.0% | -3.3% | +4.9% | -15.5% | -2.2% | -26.9% | +3.6% | +2.6% | +6.9% |
| YoY Change | — | — | — | — | +6.5% | -1.3% | +12.4% | +10.9% | +11.7% | +135.5% | +134.4% | +165.1% | +124.8% | +17.4% | -8.2% | -16.2% | -36.7% | -37.5% | -24.0% | -17.0% |
Range$292.60M – $873.40M
CAGR+14.8%
Avg YoY Growth+29.9%
Median YoY Growth+8.7%
Current Streak3 quarters growth
Total Current Liabilities at Other Companies
Frequently Asked Questions
- What is United Therapeutics's total current liabilities?
- United Therapeutics (UTHR) reported total current liabilities of $599.10M in Q1 2026.
- How has United Therapeutics's total current liabilities changed year-over-year?
- United Therapeutics's total current liabilities decreased by 17.0% year-over-year, from $721.50M to $599.10M.
- What is the long-term trend for United Therapeutics's total current liabilities?
- Over 5 years (2020 to 2025), United Therapeutics's total current liabilities has grown at a 11.6% compound annual growth rate (CAGR), from $323.30M to $560.60M.
- What does total current liabilities mean?
- The total amount of all debts and obligations due within the next twelve months.